Asymptomatic pulmonary nodules in a patient with early-stage breast cancer: Cryptococcus infection

International Journal of Infectious Diseases

Volumn 14, Issue 1, 2010, Pages

  Ou, Kuang Wen ^a   Hsu, Kuo Feng ^a   Cheng, Yeung Leung ^a   Hsu, Giu Cheng ^a   Hsu, Huan Ming ^a   Yu, Jyh Cherng ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Breast cancer; Cryptococcus infection; Metastasis; Pulmonary nodule

Indexed keywords

FLUCONAZOLE;

ADULT; ARTICLE; BREAST CANCER; CANCER STAGING; CASE REPORT; CRYPTOCOCCOSIS; CRYPTOCOCCUS; EARLY CANCER; FEMALE; HUMAN; LUNG BIOPSY; LUNG NODULE; LUNG TUMOR; MASTECTOMY; METASTASIS; THORACOSCOPY;

ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUCONAZOLE; HUMANS; LUNG; LUNG NEOPLASMS; MIDDLE AGED; PNEUMONIA;

EID: 75049083959     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2009.03.007     Document Type: Article

References (15)

1. Casey J.J., Stempel B.G., Scanlon E.F., and Fry W.A. The solitary pulmonary nodule in the patient with breast cancer. Surgery 96 (1984) 801-805
2. Cahan W.G., and Castro E.B. Significance of a solitary lung shadow in patients with breast cancer. Ann Surg 181 (1975) 137-143
3. Chang E.Y., Johnson W., Karamlou K., Khaki A., Komanapalli C., and Walts D. The evaluation and treatment implications of isolated pulmonary nodules in patients with a recent history of breast cancer. Am J Surg 191 (2006) 641-645
4. Tanaka F., Li M., Hanaoka N., Bando T., Fukuse T., Hasegawa S., et al. Surgery for pulmonary nodules in breast cancer patients. Ann Thorac Surg 79 (2005) 1711-1715
5. Rena O., Papalia E., Ruffini E., Filosso P.L., Oliaro A., Maggi G., et al. The role of surgery in the management of solitary pulmonary nodule in breast cancer patients. Eur J Surg Oncol 33 (2007) 546-550
6. Hajjeh R.A., Conn L.A., Stephens D.S., Baughman W., Hamill R., Graviss E., et al. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis 179 (1999) 449-454
7. Luo L., and Li T. Idiopathic CD4 lymphocytopenia and opportunistic infection-an update. FEMS Immunol Med Microbiol 54 (2008) 283-289
8. Goldman D.L., Khine H., Abadi J., Lindenberg D.J., Pirofski La, Niang R., et al. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 107 (2001) E66
9. Ching C.K., Smith P.G., and Long R.G. Tamoxifen-associated hepatocellular damage and agranulocytosis. Lancet 339 (1992) 940
10. Lerner H.J., Band P.R., Israel L., and Leung B.S. Phase II study of tamoxifen: report of 74 patients with stage IV breast cancer. Cancer Treat Rep 60 (1976) 1431-1435
11. Chayakulkeeree M., and Perfect J.R. Cryptococcosis. Infect Dis Clin N Am 20 (2006) 507-544
12. Nadrous H.F., Antonios V.S., Terrell C.L., and Ryu J.H. Pulmonary cryptococcosis in nonimmunocompromised patients. Chest 124 (2003) 2143-2147
13. Yang C.J., Hwang J.J., Wang T.H., Cheng M.S., Kang W.Y., and Chen T.C. Clinical and radiographic presentations of pulmonary cryptococcosis in immunocompetent patients. Scand J Infect Dis 38 (2006) 788-793
14. Chang W.C., Tzao C., Hsu H.H., Lee S.C., Huang K.L., Tung H.J., et al. Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised Patients. Chest 129 (2006) 333-340
15. Kontoyiannis D.P., Peitsch W.K., Reddy B.T., Whimbey E.E., Han X.Y., Bodey G.P., et al. Cryptococcosis in patients with cancer. Clin Infect Dis 32 (2001) E145-E150